VBIO
Vitality Biopharma Inc
PINK: VBIO · HEALTHCARE · BIOTECHNOLOGY
$0.98
+2.06% today
Updated 2026-04-30
Market cap
$19.77M
P/E ratio
—
P/S ratio
8.04x
EPS (TTM)
$-0.03
Dividend yield
—
52W range
$0 – $0
Volume
0.3M
Vitality Biopharma Inc (VBIO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $245680.00 | $248348.00 | $163363.00 | $102419.00 | $258288.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | +1.1% | -34.2% | -37.3% | +152.2% | -100.0% | — |
| Cost of revenue | — | — | — | $156400.00 | $121341.00 | $149478.00 | $108255.00 | $77943.00 | $454767.00 | — | — |
| Gross profit | — | — | — | $-156400.00 | $124339.00 | $98870.00 | $55108.00 | $24476.00 | $-196479.00 | — | — |
| Gross margin | — | — | — | — | 50.6% | 39.8% | 33.7% | 23.9% | -76.1% | — | — |
| R&D | — | — | $255000.00 | $575092.00 | $1.13M | $613119.00 | $893960.00 | $1.90M | $1.80M | $1.01M | $408905.00 |
| SG&A | $30000.00 | $1.26M | $2.55M | $2.87M | $2.80M | $2.23M | $2.63M | $2.52M | $4.14M | $2.68M | $1.93M |
| Operating income | — | — | — | $-3.60M | $-3.81M | $-2.74M | $-3.47M | $-4.40M | $-5.68M | $-3.69M | $-2.34M |
| Operating margin | — | — | — | — | -1548.8% | -1104.0% | -2125.1% | -4292.9% | -2199.9% | — | — |
| EBITDA | — | — | — | — | — | — | — | $-4.31M | $-13.10M | — | — |
| EBITDA margin | — | — | — | — | 0.0% | 0.0% | 0.0% | -4207.2% | -5072.8% | — | — |
| EBIT | — | — | — | $-3.40M | $-4.04M | $-140962.00 | $-5.22M | $-4.40M | $-4.57M | $-3.69M | $-2.34M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | — | — | — | $-4.15M | $-4.05M | $-141325.00 | $-5.22M | $-4.31M | $-13.12M | $-4.37M | $-880851.00 |
| Net income growth (YoY) | — | — | — | — | +2.5% | +96.5% | -3593.2% | +17.4% | -204.5% | +66.7% | +79.8% |
| Profit margin | — | — | — | — | -1647.8% | -56.9% | -3195.0% | -4207.2% | -5080.2% | — | — |